Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Single-site, Open-label, Pharmacokinetic Study of Intermittent Intraperitoneal Vancomycin in Adult Subjects Receiving Automated Peritoneal Dialysis

NCT03685747 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT03685747
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03685747 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Single-site, Open-label, Pharmacokinetic Study of Intermittent Intraperitoneal Vancomycin in Adult Subjects Receiving Automated Peritoneal Dialysis
Lead sponsor
Thomas Jefferson University
Phase
Phase 1
Overall status
Completed
Start date
November 15, 2018
Completion date
October 1, 2020
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peritoneal dialysis-associated peritonitis